These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27624090)

  • 1. Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells.
    Lachmandas E; Beigier-Bompadre M; Cheng SC; Kumar V; van Laarhoven A; Wang X; Ammerdorffer A; Boutens L; de Jong D; Kanneganti TD; Gresnigt MS; Ottenhoff TH; Joosten LA; Stienstra R; Wijmenga C; Kaufmann SH; van Crevel R; Netea MG
    Eur J Immunol; 2016 Nov; 46(11):2574-2586. PubMed ID: 27624090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial Cells Attenuate Toll-Like Receptor-Mediated Inflammatory Responses in Monocyte-Derived Macrophage-Like Cells to
    Yang Y; Sun Y; Xu J; Bao K; Luo M; Liu X; Wang Y
    Mediators Inflamm; 2018; 2018():3685948. PubMed ID: 30356420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Gene Expression Analysis of Mtb-Infected DC Highlights the Rapamycin-Driven Modulation of Regulatory Cytokines
    Etna MP; Severa M; Licursi V; Pardini M; Cruciani M; Rizzo F; Giacomini E; Macchia G; Palumbo O; Stallone R; Carella M; Livingstone M; Negri R; Pellegrini S; Coccia EM
    Front Immunol; 2021; 12():649475. PubMed ID: 33936070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection.
    Paik S; Jo EK
    Front Immunol; 2020; 11():603951. PubMed ID: 33262773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
    Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
    Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y; Zhao Y; Guo L
    Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages.
    Shen J; Fu Y; Liu F; Ning B; Jiang X
    Inflammation; 2023 Oct; 46(5):1749-1763. PubMed ID: 37212951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 kinase via mechanistic target of rapamycin signaling.
    Zhou X; Yang J; Zhang Z; Zhang L; Lie L; Zhu B; Xu L; Gao Y; Du X; Huang Y; Wang R; Liu H; Li Y; Hu S; Zhou C; Wen Q; Pan Q; Ma L
    J Infect; 2019 Sep; 79(3):262-276. PubMed ID: 31226272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.
    Lachmandas E; van den Heuvel CN; Damen MS; Cleophas MC; Netea MG; van Crevel R
    J Diabetes Res; 2016; 2016():6014631. PubMed ID: 27057552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG-induced trained immunity in macrophage: reprograming of glucose metabolism.
    Liu Y; Liang S; Ding R; Hou Y; Deng F; Ma X; Song T; Yan D
    Int Rev Immunol; 2020; 39(3):83-96. PubMed ID: 31933415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With
    Phelan JJ; McQuaid K; Kenny C; Gogan KM; Cox DJ; Basdeo SA; O'Leary S; Tazoll SC; Ó Maoldomhnaigh C; O'Sullivan MP; O'Neill LA; O'Sullivan MJ; Keane J
    Front Immunol; 2020; 11():836. PubMed ID: 32477344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway.
    Liu J; Ming S; Song W; Meng X; Xiao Q; Wu M; Wu Y; Xie H; Zhou J; Zhong H; Huang X
    Int Immunopharmacol; 2021 Feb; 91():107215. PubMed ID: 33348294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
    Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
    Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic Dynamics of Macrophage Immunometabolism during
    Shi L; Jiang Q; Bushkin Y; Subbian S; Tyagi S
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin.
    VanderWeele DJ; Zhou R; Rudin CM
    Mol Cancer Ther; 2004 Dec; 3(12):1605-13. PubMed ID: 15634654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.